ISO 15378: pharmaceutical packaging standard

ISO 15378 is the quality management standard that applies to primary packaging materials for medicines. Its official title — published in English, the drafting language of ISO standards — is "Primary packaging materials for medicinal products — Particular requirements for the application of ISO 9001:2015, with reference to good manufacturing practice (GMP)." The version currently in force dates from 2017. ISO confirmed it in 2023, meaning the technical committee judged the text still fit for the sector's needs at that date, without a substantial revision. Amendment 1, published in 2024, added provisions on climate change.

The title says it plainly: this is not a stand-alone text but an application standard. ISO 15378 starts from ISO 9001:2015 — the generic quality management reference, valid for any sector of activity — and adds to it the particular requirements that manufacturing pharmaceutical materials imposes: good manufacturing practice, or GMP. A supplier certified to ISO 15378 therefore applies two layers of requirements stacked on top of each other: the quality management system of ISO 9001, and above it, the GMP requirements specific to its sector. The standard does not replace ISO 9001, it completes it.

The standard's scope is precise: it targets primary packaging materials, those that come into direct contact with the medicine — a bottle holding a syrup, a cap sealing it, a closure touching the preparation. It is this direct proximity to the product that justifies stricter requirements: a defect on this kind of packaging is no longer just a presentation flaw, it becomes a risk for the person receiving the medicine. A shipping carton or an outer wrap, which never touch the product, remain outside this scope.

For a buyer, this distinction has a concrete consequence: a supplier's ISO 15378 certification only means something in relation to what it actually covers. It certifies that a quality management system has been audited by a third-party body, against an internationally recognised reference, and that it specifically incorporates the requirements tied to the risk posed by packaging in direct contact with a medicine. It is a guarantee of method and documented traceability, verifiable with the certifying body — not a claim the supplier makes about its own products.

This regular maintenance — confirmation in 2023, amendment in 2024 — reflects how an ISO standard normally operates: a published text is not frozen, it stays under the watch of its technical committee, which confirms it, amends it, or withdraws it depending on whether it still matches the sector's needs. It is therefore worth checking, when consulting the standard, that it is indeed the 2017 edition as amended in 2024, and not an earlier version.